{{Rsnum
|rsid=80338784
|Chromosome=17
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=SCN4A
|position=63959278
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=SCN4A
}}{{omim
|id=603967
|rsnum=80338784
|variant=0015
}}{{ClinVar
|rsid=80338784
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=62036638
|CHROM=17
|dbSNPBuildID=131
|SSR=0
|SAO=1
|VP=0x050168000000000002110100
|GENEINFO=SCN4A:6329
|GENE_NAME=SCN4A
|GENE_ID=6329
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000017.10:g.62036638C>T
|CLNSRC=GeneReviews; OMIM Allelic Variant
|CLNORIGIN=0
|CLNSRCID=NBK1338; 603967.0015
|CLNSIG=5
|CLNCUI=C2750061; CN031165
|CLNDBN=Hypokalemic periodic paralysis, type 2; Hypokalemic periodic paralysis 1
|Disease=Hypokalemic periodic paralysis; Hypokalemic periodic paralysis 1
|CLNACC=RCV000006274.2; RCV000020260.1
|Tags=RV;PM;PMC;SLO;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet; GeneReviews:GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1338:C2750061:613345:681; NBK1338:NBK1496:CN031165:170400:681
}}{{PMID Auto
|PMID=10599760
|Title=A novel sodium channel mutation in a family with hypokalemic periodic paralysis.
}}

{{PMID Auto
|PMID=11102465
|Title=The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.
}}

{{PMID Auto
|PMID=15557532
|Title=SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide.
}}